Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.100
-0.020 (-0.94%)
At close: Sep 8, 2026, 4:00 PM EDT
2.100
0.00 (0.00%)
After-hours: Sep 8, 2026, 4:15 PM EDT
BDTX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.19 | 20.99 | 36.44 | 56.22 | 34.32 | 65.8 |
Short-Term Investments | 91.31 | 107.66 | 62.14 | 75.18 | 88.49 | 143.99 |
Cash & Short-Term Investments | 110.51 | 128.65 | 98.58 | 131.4 | 122.81 | 209.79 |
Cash Growth | -22.63% | 30.51% | -24.98% | 7.00% | -41.46% | -33.41% |
Prepaid Expenses | 4.89 | 3.79 | 2.6 | 2.63 | 4.9 | 5.92 |
Total Current Assets | 115.39 | 132.44 | 101.18 | 134.03 | 127.71 | 215.7 |
Property, Plant & Equipment | 8.52 | 9.67 | 20.4 | 23.71 | 27.38 | 30.74 |
Other Long-Term Assets | 1.12 | 0.9 | 1.07 | 0.82 | 1.17 | 1.24 |
Total Assets | 125.03 | 143.01 | 122.64 | 158.57 | 156.26 | 247.68 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.4 | 0.58 | 4.01 | 2.32 | 1.88 | 4.11 |
Accrued Expenses | 10.56 | 11.44 | 13.16 | 14.21 | 10.54 | 19.22 |
Current Portion of Leases | 3.88 | 3.71 | 3.4 | 3.11 | 2.84 | 0.32 |
Total Current Liabilities | 15.84 | 15.73 | 20.57 | 19.65 | 15.26 | 23.64 |
Long-Term Leases | 13.1 | 15.07 | 18.78 | 22.19 | 25.3 | 28.14 |
Total Liabilities | 28.94 | 30.8 | 39.36 | 41.83 | 40.56 | 51.78 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 579.83 | 576.84 | 570.36 | 534.19 | 452.5 | 440.13 |
Retained Earnings | -483.68 | -464.74 | -487.11 | -417.43 | -334.99 | -243.82 |
Comprehensive Income & Other | -0.07 | 0.1 | 0.02 | -0.03 | -1.82 | -0.41 |
Total Common Equity | 96.09 | 112.21 | 83.29 | 116.74 | 115.7 | 195.9 |
Shareholders' Equity | 96.09 | 112.21 | 83.29 | 116.74 | 115.7 | 195.9 |
Total Liabilities & Equity | 125.03 | 143.01 | 122.64 | 158.57 | 156.26 | 247.68 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 16.97 | 18.78 | 22.19 | 25.3 | 28.14 | 28.46 |
Net Cash (Debt) | 93.54 | 109.87 | 76.39 | 106.1 | 94.67 | 181.33 |
Net Cash Growth | -23.38% | 43.83% | -28.00% | 12.08% | -47.79% | -40.81% |
Net Cash Per Share | 1.64 | 1.91 | 1.39 | 2.41 | 2.61 | 5.01 |
Filing Date Shares Outstanding | 57.45 | 57.29 | 56.66 | 51.72 | 36.48 | 36.27 |
Total Common Shares Outstanding | 57.45 | 57.14 | 56.64 | 51.65 | 36.43 | 36.23 |
Working Capital | 99.55 | 116.71 | 80.6 | 114.39 | 112.45 | 192.06 |
Book Value Per Share | 1.67 | 1.96 | 1.47 | 2.26 | 3.18 | 5.41 |
Tangible Book Value | 96.09 | 112.21 | 83.29 | 116.74 | 115.7 | 195.9 |
Tangible Book Value Per Share | 1.67 | 1.96 | 1.47 | 2.26 | 3.18 | 5.41 |
Machinery | - | - | 0.02 | 0.02 | 0.83 | 0.82 |
Construction In Progress | - | - | - | - | - | 0.15 |
Leasehold Improvements | 1.59 | 1.59 | 2.51 | 2.51 | 2.51 | 2.44 |